Updated on 2026/03/05

写真a

 
FUKUMURA Shinobu
 
Organization
School of Medicine Department of Pediatrics Associate Professor
Title
Associate Professor
Profile

小児神経専門です。主にてんかんおよび遺伝性疾患の研究、臨床を行っています。

External link

Degree

  • 医学博士 ( 2018.3   札幌医科大学 )

Research Interests

  • てんかん

  • 遺伝

  • 再生医療

Research Areas

  • Life Science / Embryonic medicine and pediatrics  / てんかん

Professional Memberships

Committee Memberships

  • 日本てんかん学会   評議員  

    2021.8   

    　 More details

    Committee type：Academic society

    researchmap

  • 日本小児神経学会   評議員  

    2019   

    　 More details

    Committee type：Academic society

    researchmap

  • 人類遺伝学会   評議員  

    2016 - 2019   

    　 More details

    Committee type：Academic society

    researchmap

Papers

  • Therapeutic Efficacy of Mesenchymal Stem Cells in Modulating Oxidative Stress in Puromycin-Induced Nephropathy. International journal

    Yusuke Iizuka, Masanori Sasaki, Kojiro Terada, Takuro Sakai, Yoshinobu Nagaoka, Shinobu Fukumura, Jeffery D Kocsis, Takeshi Tsugawa, Osamu Honmou

    Pathophysiology : the official journal of the International Society for Pathophysiology   32 ( 2 )   2025.5

    　More details

    Language：English   Publishing type：Research paper (scientific journal)  

    Background: Podocytes are essential for kidney function, and their dysfunction can result in nephrotic syndrome, such as minimal change disease (MCD). Oxidative stress contributes to podocyte damage. We investigated the therapeutic potential of intravenously infused mesenchymal stem cells (MSCs) in a puromycin aminonucleoside (PAN)-induced rodent MCD model, focusing on oxidative stress modulation. Methods: Sprague-Dawley rats were divided into three groups: intact, PAN-Vehicle, and PAN-MSC. MCD was induced through subcutaneous PAN injection. MSCs were infused intravenously in the PAN-MSC group on day 7. Urinary albumin, serum albumin, and creatinine levels were assessed. Histological analysis of the renal cortex was performed. Podocyte protein (NPHS1, NPHS2, and PODXL) and antioxidant enzyme (SOD1, SOD2, and GPX1) levels were measured using quantitative real-time reverse-transcription PCR (qRT-PCR). Results: MSC infusion significantly reduced proteinuria and restored podocyte structure in the PAN-MSC group. Electron microscopy revealed that infused MSCs could inhibit the fusion of the foot process induced by PAN injection. qRT-PCR showed that intravenous infusion of MSCs rescued the inhibition of GPX1 expression. GFP-labeled MSCs accumulated at the podocyte injury sites. Conclusion: Systemic MSC infusion mitigates PAN-induced MCD by reducing proteinuria, preserving podocyte structure, and modulating oxidative stress via the GPX1 pathway, offering a potential therapeutic approach for nephrotic syndrome.

    DOI： 10.3390/pathophysiology32020019

    PubMed

    researchmap

  • Identifying pathogenic variants in rare pediatric neurological diseases using exome sequencing. International journal

    Kazuyuki Komatsu, Mitsuhiro Kato, Kazuo Kubota, Shinobu Fukumura, Keitaro Yamada, Ikumi Hori, Kenji Shimizu, Sachiko Miyamoto, Kaori Yamoto, Takuya Hiraide, Kazuki Watanabe, Shintaro Aoki, Shogo Furukawa, Taiju Hayashi, Masaharu Isogai, Takuma Harasaki, Mitsuko Nakashima, Hirotomo Saitsu

    Scientific reports   14 ( 1 )   24746 - 24746   2024.10

    　More details

    Language：English   Publishing type：Research paper (scientific journal)  

    Variant annotations are crucial for efficient identification of pathogenic variants. In this study, we retrospectively analyzed the utility of four annotation tools (allele frequency, ClinVar, SpliceAI, and Phenomatcher) in identifying 271 pathogenic single nucleotide and small insertion/deletion variants (SNVs/small indels). Although variant filtering based on allele frequency is essential for narrowing down on candidate variants, we found that 13 de novo pathogenic variants in autosomal dominant or X-linked dominant genes are registered in gnomADv4.0 or 54KJPN, with an allele frequency of less than 0.001%, suggesting that very rare variants in large cohort data can be pathogenic de novo variants. Notably, 38.4% candidate SNVs/small indels are registered in the ClinVar database as pathogenic or likely pathogenic, which highlights the significance of this database. SpliceAI can detect candidate variants affecting RNA splicing, leading to the identification of four variants located 11 to 50 bp away from the exon-intron boundary. Prioritization of candidate genes by proband phenotype using the PhenoMatcher module revealed that approximately 95% of the candidate genes had a maximum PhenoMatch score ≥ 0.6, suggesting the utility of phenotype-based variant prioritization. Our results suggest that a combination of multiple annotation tools and appropriate evaluation can improve the diagnosis of rare diseases.

    DOI： 10.1038/s41598-024-75020-0

    PubMed

    researchmap

  • Therapeutic efficacy of intravenous infusion of mesenchymal stem cells in rat perinatal brain injury. International journal

    Kojiro Terada, Masanori Sasaki, Hiroshi Nagahama, Yuko Kataoka-Sasaki, Shinichi Oka, Ryo Ukai, Takahiro Yokoyama, Yusuke Iizuka, Takuro Sakai, Shinobu Fukumura, Takeshi Tsugawa, Jeffery D Kocsis, Osamu Honmou

    Pediatric research   2023.7

    　More details

    Language：English   Publishing type：Research paper (scientific journal)  

    BACKGROUND: Perinatal brain injury is multifactorial and primarily associated with brain prematurity, inflammation, and hypoxia-ischemia. Although recent advances in perinatal medicine have improved the survival rates of preterm infants, neurodevelopmental disorders remain a significant complication. We tested whether the intravenous infusion of mesenchymal stem cells (MSCs) had therapeutic efficacy against perinatal brain injury in rats. METHODS: Pregnant rats at embryonic day (E) 18 received lipopolysaccharide and the pups were born at E21. On postnatal day (PND) 7, the left common carotid artery of each pup was ligated, and they were exposed to 8% oxygen for 2 h. They were randomized on PND10, and MSCs or vehicle were intravenously infused. We performed behavioral assessments, measured brain volume using MRI, and performed histological analyses on PND49. RESULTS: Infused MSCs showed functional improvements in our model. In vivo MRI revealed that MSC infusion increased non-ischemic brain volume compared to the vehicle group. Histological analyses showed that cortical thickness, the number of NeuN+ and GAD67+ cells, and synaptophysin density in the non-ischemic hemisphere in the MSC group were greater than the vehicle group, but less than the control group. CONCLUSIONS: Infused MSCs improve sensorimotor and cognitive functions in perinatal brain injury and enhance neuronal growth. IMPACT: Intravenous infusion of MSCs improved neurological function in rats with perinatal brain injury, including motor, sensorimotor, cognitive, spatial, and learning memory. Infused MSCs increased residual (non-ischemic) tissue volume, number of neuronal cells, GABAergic cells, and cortical synapses in the contralesional (right) hemisphere. Intravenous administration of MSC might be suitable for the treatment of perinatal brain injury.

    DOI： 10.1038/s41390-023-02717-9

    PubMed

    researchmap

  • 高クレアチンキナーゼ血症から偶発的に診断されたベッカー型7例を含む筋ジストロフィー9例の臨床的検討

    伊藤 拓郎, 福村 忍, 土田 晃輔, 山本 晃代, 津川 毅, 安藤 悠開, 下村 遼太郎, 飯塚 裕典, 星野 恵美子, 櫻井 のどか, 平川 賢史, 布施 茂登, 森 俊彦

    臨床小児医学   70 ( 1-6 )   15 - 19   2023.3

    　More details

    Language：Japanese   Publisher：(財)小児愛育協会  

    Ichushi

    researchmap

  • 聴覚失認を合併した欠神てんかんの1例

    山本 晃代, 土田 晃輔, 加藤 辰輔, 福村 忍, 小笠原 徳子

    てんかん研究   40 ( 1 )   86 - 87   2022.6

    　More details

    Language：Japanese   Publisher：(一社)日本てんかん学会  

    Ichushi

    researchmap

  • 聴覚失認を合併した欠神てんかんの1例

    山本 晃代, 土田 晃輔, 加藤 辰輔, 福村 忍, 小笠原 徳子

    てんかん研究   40 ( 1 )   86 - 87   2022.6

    　More details

    Language：Japanese   Publisher：(一社)日本てんかん学会  

    Ichushi

    researchmap

  • 重度の低髄鞘化および精神運動発達遅滞を認めた新規TMEM63Aバリアントの1例

    福村 忍, 平出 拓也, 山本 晃代, 土田 晃輔, 青戸 一司, 中島 光子, 才津 浩智

    脳と発達   54 ( Suppl. )   S214 - S214   2022.5

    　More details

    Language：Japanese   Publisher：(一社)日本小児神経学会  

    Ichushi

    researchmap

  • 過去6年間にてんかん外科治療を行った小児てんかん患者11例のまとめ

    山本 晃代, 土田 晃輔, 福村 忍, 越智 さと子, 菅野 彩, 江夏 怜, 三國 信啓

    脳と発達   54 ( Suppl. )   S216 - S216   2022.5

    　More details

    Language：Japanese   Publisher：(一社)日本小児神経学会  

    Ichushi

    researchmap

  • A new case of concurrent existence of PRRT2-associated paroxysmal movement disorders with c.649dup variant and 16p11.2 microdeletion syndrome. International journal

    Kazuyuki Komatsu, Shinobu Fukumura, Kimio Minagawa, Mitsuko Nakashima, Hirotomo Saitsu

    Brain & development   44 ( 7 )   474 - 479   2022.4

    　More details

    Language：English  

    BACKGROUND: The PRRT2 gene located at 16p11.2 encodes proline-rich transmembrane protein 2. In recent reviews, clinical spectrum caused by pathogenic PRRT2 variants is designated as PRRT2-associated paroxysmal movement disorders, which include paroxysmal kinesigenic dyskinesia, benign familial infantile epilepsy, and infantile convulsions with choreoathetosis, and hemiplegic migraine. The recurrent 16p11.2 microdeletion encompassing PRRT2 has also been reported to cause neurodevelopmental syndrome, associated with autism spectrum disorder. Although PRRT2 variants and 16p11.2 microdeletion cause each disease with the autosomal dominant manner, rare cases with bi-allelic PRRT2 variants or concurrent existence of PRRT2 variants and 16p11.2 microdeletion have been reported to show more severe phenotypes. CASE REPORT: A 22-year-old man presents with episodic ataxia, paroxysmal kinesigenic dyskinesia, seizure, intellectual disability and autism spectrum disorder. He also has obesity, hypertension, hyperuricemia, and mild liver dysfunction. Exome sequencing revealed a c.649dup variant in PRRT2 in one allele and a de novo 16p11.2 microdeletion in another allele. CONCLUSIONS: Our case showed combined clinical features of PRRT2-associated paroxysmal movement disorders and 16p11.2 microdeletion syndrome. We reviewed previous literatures and discussed phenotypic features of patients who completely lack the PRRT2 protein.

    DOI： 10.1016/j.braindev.2022.03.008

    PubMed

    researchmap

  • 繰り返す腰椎穿刺により脳脊髄液漏出をきたした脊髄性筋萎縮症I型の1例

    加藤 辰輔, 土田 晃輔, 福村 忍, 津川 毅

    臨床小児医学   69 ( 1-6 )   55 - 59   2022.3

    　More details

    Language：Japanese   Publisher：(財)小児愛育協会  

    Ichushi

    researchmap

  • Two novel heterozygous variants in ATP1A3 cause movement disorders. International journal

    Shogo Furukawa, Sachiko Miyamoto, Shinobu Fukumura, Kazuo Kubota, Toshiaki Taga, Mitsuko Nakashima, Hirotomo Saitsu

    Human genome variation   9 ( 1 )   7 - 7   2022.2

    　More details

    Language：English   Publishing type：Research paper (scientific journal)  

    Variants in ATP1A3 cause neuropsychiatric disorders, especially those characterized by movement disorders. In this study, we performed whole exome sequencing for two patients with movement disorders and identified two novel heterozygous ATP1A3 variants, a missense c.2408G>A variant and an indel c.2672_2688+10delinsCAG variant. The unique indel variant occurred at the exon-intron boundary at the 3' end of exon 19, and mRNA analysis revealed that this variant caused in-frame indel alteration at the Ser891_Trp896 residue.

    DOI： 10.1038/s41439-022-00184-y

    PubMed

    researchmap

  • An intronic GNAO1 variant leading to in-frame insertion cause movement disorder controlled by deep brain stimulation. International journal

    Sachiko Miyamoto, Mitsuko Nakashima, Shinobu Fukumura, Satoko Kumada, Hirotomo Saitsu

    Neurogenetics   23 ( 2 )   129 - 135   2022.2

    　More details

    Language：English   Publishing type：Research paper (scientific journal)  

    GNAO1 variants are associated with a wide range of neurodevelopmental disorders including epileptic encephalopathies and movement disorders. It has been reported that some GNAO1 variants are associated with movement disorders, and the 207-246 amino acid region was proposed as a mutational hotspot. Here, we report an intronic variant (NM_020988.3:c.724-8G>A) in GNAO1 in a Japanese girl who showed mild developmental delay and movement disorders including dystonia and myoclonus. Her movement disorders were improved by deep brain stimulation treatment as previously reported. This variant has been recurrently reported in four patients and was transmitted from her mother who possessed the variant as low-prevalent mosaicism. Using RNA extracted from lymphoblastoid cells derived from the patient, we demonstrated that the variant caused abnormal splicing of in-frame 6-bp intronic retention, leading to 2 amino acid insertion (p.Thr241_Asn242insProGln). Immunoblotting and immunostaining using WT and mutant GNAO1 vectors showed no significant differences in protein expression levels, but the cellular localization pattern of this mutant was partially shifted to the cytoplasm whereas WT was exclusively localized in the cellular membrane. Our report first clarified abnormal splicing and resulting mutant protein caused by the c.724-8G>A variant.

    DOI： 10.1007/s10048-022-00686-5

    PubMed

    researchmap

  • A novel de novo TMEM63A variant in a patient with severe hypomyelination and global developmental delay. International journal

    Shinobu Fukumura, Takuya Hiraide, Akiyo Yamamoto, Kousuke Tsuchida, Kazushi Aoto, Mitsuko Nakashima, Hirotomo Saitsu

    Brain & development   44 ( 2 )   178 - 183   2021.9

    　More details

    Language：English  

    BACKGROUND: Heterozygous variants in TMEM63A have been recently identified as the cause of infantile-onset transient hypomyelination. To date, four TMEM63A variants have been reported in five patients. These patients exhibited favorable clinical course, developmental progress, and completion of myelination. CASE REPORT: The patient was a 5-year-old girl with severe global developmental delay, absent speech, no turning over, no gazing, hypotonia, and daily episodes of autonomic seizures. Brain MRI showed hypomyelination of deep and subcortical white matter that appeared hyperintense in T2-weighted imaging from 2 months of age and that showed no change at 4 years of age. Exome sequencing of the patient and her parents revealed a novel de novo missense variant, NM_014698.3:c.1658G>T, p.(Gly553Val), in the TMEM63A gene, which was confirmed by Sanger sequencing. The variant has not been registered in public databases, and it substitutes a highly conserved glycine residue located in a pore-lining transmembrane helix. No other candidate variants were identified. CONCLUSIONS: Although TMEM63A variants are generally thought to cause transient hypomyelination with favorable developmental progress, identification of a de novo TMEM63A variant in our patient suggests that the TMEM63A-related clinical spectrum is broad and includes severe developmental delay with seizures.

    DOI： 10.1016/j.braindev.2021.09.006

    PubMed

    researchmap

  • レスベラトロールによる筋ジストロフィーの治療

    福村 忍, 川村 健太郎, 山本 晃代, 堀尾 嘉幸, 久野 篤史, 堤 裕幸

    BIO Clinica   36 ( 9 )   910 - 914   2021.8

    　More details

    Language：Japanese   Publisher：(株)北隆館  

    Ichushi

    researchmap

  • FGF14遺伝子バリアントを認めた発作性非運動誘発性ジスキネジアの1例

    土田 晃輔, 福村 忍, 加藤 辰輔, 續 晶子, 平出 拓也, 中島 光子, 才津 浩智, 川崎 幸彦

    脳と発達   53 ( Suppl. )   S235 - S235   2021.5

    　More details

    Language：Japanese   Publisher：(一社)日本小児神経学会  

    Ichushi

    researchmap

  • A case of paroxysmal kinesigenic dyskinesia suspected to be reflex epilepsy.

    Chie Nakayama-Kamada, Rei Enatsu, Shinobu Fukumura, Tomoyoshi Kuribara, Satoko Ochi, Nobuhiro Mikuni

    Nagoya journal of medical science   83 ( 2 )   361 - 365   2021.5

    　More details

    Language：English  

    An 11-year-old male patient developed weakness or right arm elevation after sudden movement at the age of eight. Reflex epilepsy was initially suspected; however, magnetic resonance imaging and electroencephalography (EEG) revealed no abnormality. Video-EEG monitoring was performed, but no change was noted during attacks of weakness. He was diagnosed with paroxysmal kinesigenic dyskinesia (PKD) and carbamazepine has stopped his attacks. PKD is a rare neurological disorder characterized by brief attacks of involuntary movement triggered by sudden voluntary movements, which may be confused with reflex epilepsy. PKD should be considered as a differential diagnosis of reflex epilepsy.

    DOI： 10.18999/nagjms.83.2.361

    PubMed

    researchmap

  • KCNJ5遺伝子バリアントは不完全浸透を示し家族性周期性四肢麻痺の原因になる

    平出 拓也, 福村 忍, 山本 晃代, 中島 光子, 才津 浩智

    脳と発達   53 ( Suppl. )   S238 - S238   2021.5

    　More details

    Language：Japanese   Publisher：(一社)日本小児神経学会  

    Ichushi

    researchmap

  • IQSEC2遺伝子の新規突然変異による発達性てんかん性脳症の男児例 Reviewed

    田中 亮介, 黒田 真実, 竹口 諒, 福村 忍, 要 匡, 高橋 悟

    脳と発達   53 ( 2 )   129 - 132   2021.3

    　More details

  • Familial periodic paralysis associated with a rare KCNJ5 variant that supposed to have incomplete penetrance. International journal

    Takuya Hiraide, Shinobu Fukumura, Akiyo Yamamoto, Mitsuko Nakashima, Hirotomo Saitsu

    Brain & development   43 ( 3 )   470 - 474   2021.3

    　More details

    Language：English  

    BACKGROUND: The periodic paralyses are a group of skeletal muscle channelopathies caused by variants in several ion channel genes. Potassium Inwardly Rectifying Channel Subfamily J Member 5 (KCNJ5) encodes the G-protein-activated inwardly rectifying potassium channel 4 (Kir3.4) and the heterozygous KCNJ5 variants cause familial hyperaldosteronism and long QT syndrome (LQTS). Recent studies suggested that variants in KCNJ5 are also causative for Andersen-Tawil syndrome, which showed periodic paralysis and characteristic electrocardiogram features. CLINICAL REPORT: We found a heterozygous KCNJ5 variant c.1159G > C, p.(Gly387Arg) in an individual with familial periodic paralysis using exome sequencing. Sanger sequencing revealed that this variant was inherited from his affected mother. The same variant had been previously found in two cases of familial LQTS or Andersen-Tawil syndrome, and functional analysis suggested that this variant might have loss of function effect on channel activity. However, the allele frequency of c.1159G > C variant in an East Asian population of public databases ranged from 0.21% to 0.25%, indicating possible incomplete penetrance. CONCLUSIONS: Our two patients expand the phenotypic spectrum associated with the c.1159G > C KCNJ5 variant, though the variant has very low penetrance.

    DOI： 10.1016/j.braindev.2020.10.010

    PubMed

    researchmap

  • Novel HSD17B4 Variants Cause Progressive Leukodystrophy in Childhood: Case Report and Literature Review

    Akiyo Yamamoto, Shinobu Fukumura, Yumi Habata, Sachiko Miyamoto, Mitsuko Nakashima, Shigeo Takashima, Yukihiko Kawasaki, Nobuyuki Shimozawa, Hirotomo Saitsu

    Child Neurology Open   8   2329048X2110486 - 2329048X2110486   2021.1

    　More details

    Publishing type：Research paper (scientific journal)   Publisher：SAGE Publications  

    D-bifunctional protein (DBP) deficiency is a peroxisomal disorder with a high degree of phenotypic heterogeneity. Some patients with DBP deficiency develop progressive leukodystrophy in childhood. We report a 6-year-old boy with moderate hearing loss who presented with developmental regression. Brain magnetic resonance imaging demonstrated progressive leukodystrophy. However, very long chain fatty acids (VLCFAs) in the plasma were at normal levels. Whole-exome sequencing revealed compound heterozygous variants in HSD17B4 (NM_000414.3:c.[350A > T];[394C > T], p.[[Asp117Val]];[[Arg132Trp]]). The c.394C > T variant has been identified in patients with DBP deficiency and is classified as likely pathogenic, while the c.350A > T variant was novel and classified as uncertain significance. Although one of the two variants was classified as uncertain significance, an accumulation of phytanic and pristanic acids was identified in the patient, confirming type III DBP deficiency. DBP deficiency should be considered as a diagnosis in children with progressive leukodystrophy and hearing loss even if VLCFAs are within normal levels.

    Other Link： http://journals.sagepub.com/doi/full-xml/10.1177/2329048X211048613

    DOI： 10.1177/2329048x211048613

    researchmap

  • Resveratrol improves motor function in patients with muscular dystrophies: an open-label, single-arm, phase IIa study. International journal

    Kentaro Kawamura, Shinobu Fukumura, Koki Nikaido, Nobutada Tachi, Naoki Kozuka, Tsugumi Seino, Kingya Hatakeyama, Mitsuru Mori, Yoichi M Ito, Akiyoshi Takami, Shiro Hinotsu, Atsushi Kuno, Yukihiko Kawasaki, Yoshiyuki Horio, Hiroyuki Tsutsumi

    Scientific reports   10 ( 1 )   20585 - 20585   2020.11

    　More details

    Language：English   Publishing type：Research paper (scientific journal)  

    Muscular dystrophies (MDs) are inherited disorders characterized by progressive muscle weakness. Previously, we have shown that resveratrol (3,5,4'-trihydroxy-trans-stilbene), an antioxidant and an activator of the protein deacetylase SIRT1, decreases muscular and cardiac oxidative damage and improves pathophysiological conditions in animal MD models. To determine whether resveratrol provides therapeutic benefits to patients with MDs, an open-label, single-arm, phase IIa trial of resveratrol was conducted in 11 patients with Duchenne, Becker or Fukuyama MD. The daily dose of resveratrol was 500 mg/day, which was increased every 8 weeks to 1000 and then 1500 mg/day. Primary outcomes were motor function, evaluated by a motor function measure (MFM) scale, muscular strength, monitored with quantitative muscle testing (QMT), and serum creatine kinase (CK) levels. Adverse effects and tolerability were evaluated as secondary outcomes. Despite the advanced medical conditions of the patients, the mean MFM scores increased significantly from 34.6 to 38.4 after 24 weeks of medication. A twofold increase was found in the mean QMT scores of scapula elevation and shoulder abduction. Mean CK levels decreased considerably by 34%. Diarrhoea and abdominal pain was noted in six and three patients, respectively. Resveratrol may provide some benefit to MD patients.

    DOI： 10.1038/s41598-020-77197-6

    PubMed

    researchmap

  • IQSEC2遺伝子の新規突然変異による発達性てんかん性脳症の男児例

    田中 亮介, 黒田 真実, 竹口 諒, 福村 忍, 高橋 悟

    脳と発達   52 ( Suppl. )   S223 - S223   2020.8

    　More details

    Language：Japanese   Publisher：(一社)日本小児神経学会  

    Ichushi

    researchmap

  • Functional analysis of a double-point mutation in the KCNJ2 gene identified in a family with Andersen-Tawil syndrome. Reviewed

    Shinobu Fukumura

    J Neurol Sci   407   116521   2019.6

    　More details

    Authorship：Lead author,　Corresponding author  

    researchmap

  • Functional recovery after the systemic administration of mesenchymal stem cells in a rat model of neonatal hypoxia-ischemia. Reviewed International journal

    Sakai T, Sasaki M, Kataoka-Sasaki Y, Oka S, Nakazaki M, Fukumura S, Kobayashi M, Tsutsumi H, Kocsis JD, Honmou O

    Journal of neurosurgery. Pediatrics   22 ( 5 )   1 - 10   2018.8

    　More details

    Language：English   Publishing type：Research paper (scientific journal)  

    The authors intravenously infused mesenchymal stem cells (MSCs) into a rat model of neonatal hypoxia-ischemia and found improvements in functional outcome, increased brain volume, and enhanced synaptogenesis. The results of this animal study suggest that the intravenous administration of MSCs should be further explored as a potential treatment for patients suffering from cerebral palsy after hypoxic-ischemic encephalopathy.

    DOI： 10.3171/2018.5.PEDS1845

    PubMed

    researchmap

  • 胎生期の甲状腺機能異常が原因と思われた大後頭孔狭窄

    浜田 亮, 山本 晃代, 福村 忍, 石井 玲, 竹内 孝子, 鎌崎 穂高, 堤 裕幸

    日本小児科学会雑誌   122 ( 7 )   1255 - 1255   2018.7

    　More details

    Language：Japanese   Publisher：(公社)日本小児科学会  

    Ichushi

    researchmap

  • Rapidly progressive fatal idiopathic hypertrophic pachymeningitis with brainstem involvement in a child Reviewed

    Kosuke Tsuchida, Shinobu Fukumura, Akiyo Yamamoto, Yukinori Akiyama, Hiroshi Hirano, Hiroyuki Tsutsumi

    Child's Nervous System   34 ( 9 )   1 - 4   2018.5

    　More details

    Language：English   Publishing type：Research paper (scientific journal)   Publisher：Springer Verlag  

    DOI： 10.1007/s00381-018-3819-5

    PubMed

    researchmap

  • Intravenous infusion of mesenchymal stem cells reduces epileptogenesis in a rat model of status epilepticus Reviewed

    Shinobu Fukumura, Masanori Sasaki, Yuko Kataoka-Sasaki, Shinichi Oka, Masahito Nakazaki, Hiroshi Nagahama, Tomonori Morita, Takuro Sakai, Hiroyuki Tsutsumi, Jeffery D. Kocsis, Osamu Honmou

    Epilepsy Research   141   56 - 63   2018.3

    　More details

    Language：English   Publishing type：Research paper (scientific journal)   Publisher：Elsevier B.V.  

    DOI： 10.1016/j.eplepsyres.2018.02.008

    PubMed

    researchmap

  • Distinctive facies, macrocephaly, and developmental delay are signs of a PTEN mutation in childhood Reviewed

    Kohji Kato, Seiji Mizuno, Mie Inaba, Shinobu Fukumura, Naoko Kurahashi, Koichi Maruyama, Daisuke Ieda, Kei Ohashi, Ikumi Hori, Yutaka Negishi, Ayako Hattori, Shinji Saitoh

    Brain and Development   40 ( 8 )   678 - 684   2018

    　More details

    Language：English   Publishing type：Research paper (scientific journal)   Publisher：Elsevier B.V.  

    DOI： 10.1016/j.braindev.2018.04.008

    PubMed

    researchmap

  • Clinical and mutational spectrum of Charcot–Marie–Tooth disease type 2Z caused by MORC2 variants in Japan Reviewed

    M. Ando, Y. Okamoto, A. Yoshimura, J. H. Yuan, Y. Hiramatsu, Y. Higuchi, A. Hashiguchi, J. Mitsui, H. Ishiura, S. Fukumura, M. Matsushima, N. Ochi, J. Tsugawa, S. Morishita, S. Tsuji, H. Takashima

    European Journal of Neurology   24 ( 10 )   1274 - 1282   2017.10

    　More details

    Language：English   Publishing type：Research paper (scientific journal)   Publisher：Blackwell Publishing Ltd  

    DOI： 10.1111/ene.13360

    PubMed

    researchmap

  • Comprehensive investigation of CASK mutations and other genetic etiologies in 41 patients with intellectual disability and microcephaly with pontine and cerebellar hypoplasia (MICPCH) Reviewed

    Shin Hayashi, Daniela Tiaki Uehara, Kousuke Tanimoto, Seiji Mizuno, Yasutsugu Chinen, Shinobu Fukumura, Jun-ichi Takanashi, Hitoshi Osaka, Nobuhiko Okamoto, Johji Inazawa

    PLOS ONE   12 ( 8 )   e0181791   2017.8

    　More details

    Language：English   Publishing type：Research paper (scientific journal)  

    DOI： 10.1371/journal.pone.0181791

    PubMed

    Web of Science

    researchmap

  • A combination of genetic and biochemical analyses for the diagnosis of PI3K-AKT-mTOR pathway-associated megalencephaly Reviewed

    Yutaka Negishi, Fuyuki Miya, Ayako Hattori, Yoshikazu Johmura, Motoo Nakagawa, Naoki Ando, Ikumi Hori, Takao Togawa, Kohei Aoyama, Kei Ohashi, Shinobu Fukumura, Seiji Mizuno, Ayako Umemura, Yoko Kishimoto, Nobuhiko Okamoto, Mitsuhiro Kato, Tatsuhiko Tsunoda, Mami Yamasaki, Yonehiro Kanemura, Kenjiro Kosaki, Makoto Nakanishi, Shinji Saitoh

    BMC MEDICAL GENETICS   18 ( 1 )   4   2017.1

    　More details

    Language：English   Publishing type：Research paper (scientific journal)  

    DOI： 10.1186/s12881-016-0363-6

    PubMed

    Web of Science

    researchmap

  • Short-term efficacy and safety of rufinamide for Lennox-Gastaut syndrome. Reviewed

    Takayama R, Fukumura S, Minagawa K, Watanabe T

    No to hattatsu = Brain and development   48 ( 5 )   322 - 326   2016.9

    　More details

    Language：Japanese   Publisher：The Japanese Society of Child Neurology  

    <p>  <i><b>Objective:</b></i> We examined the short-term efficacy and safety of rufinamide (RFN) in patients with Lennox-Gastaut syndrome (LGS). <i><b>Methods:</b></i> We performed a retrospective review of clinical records of patients with LGS who started RFN treatment between July 2013 and June 2014 at the Hokkaido Medical Center for Child Health and Rehabilitation and Midorigaoka Ryo-iku-en. Efficacy and safety were evaluated when the patients had completed three months of treatment. Patients were classified into four categories according to percent seizure reduction : remission (seizure-free), response (seizure reduction≥50%), no change (seizure reduction<50% or increase) and aggravation (seizure increase≥50%). Responder rate (RR) was the percentage of patients with≥50% decrease in seizure frequency. <i><b>Results:</b></i> Thirteen LGS patients (8 males, 5 females) were studied. The efficacy for tonic seizures (13 patients) was remission 1 patient, response 3 patients, no change 8 patients and aggravation 1 patient, with RR of 30.8%. Two patients discontinued LGS due to seizure aggravation. Four patients experienced transient remission. For generalized tonic clonic seizures (2 patients), 1 patient achieved remission and 1 patient showed no change. Two patients of atonic seizures showed no change. Of 2 patients of atypical absence, 1 patient showed response and 1 patient no change. Eight patients had adverse effects such as somnolence (6 patients), sleep disturbance (1 patient), and appetite loss (4 patients) including weight loss in 2 patients. There were no severe adverse effects and no discontinuation due to adverse effects. <i><b>Conclusions:</b></i> Short-term effectiveness for tonic seizures was observed when patients with LGS were treated with RFN, with transient remission in some patients. We consider that RFN is worth trying in patients with LGS due to its efficacy for tonic seizures and absence of severe adverse effects.</p>

    DOI： 10.11251/ojjscn.48.332

    PubMed

    researchmap

  • ミトコンドリア病に対するケトン食療法の経験

    高山 留美子, 小笠原 真志, 渡邊 年秀, 福村 忍

    脳と発達   48 ( 4 )   297 - 297   2016.7

    　More details

    Language：Japanese   Publisher：(一社)日本小児神経学会  

    Ichushi

    researchmap

  • Subcortical heterotopia appearing as huge midline mass in the newborn brain Reviewed

    Shinobu Fukumura, Toshihide Watanabe, Sachiko Kimura, Satoko Ochi, Kazuhisa Yoshifuji, Hiroyuki Tsutsumi

    CHILDS NERVOUS SYSTEM   32 ( 2 )   377 - 380   2016.2

    　More details

    Language：English   Publishing type：Research paper (scientific journal)  

    DOI： 10.1007/s00381-015-2841-0

    PubMed

    Web of Science

    researchmap

  • A Mutation in the Tubulin-Encoding <i>TUBB3</i> Gene Causes Complex Cortical Malformations and Unilateral Hypohidrosis. Reviewed

    Fukumura S, Kato M, Kawamura K, Tsuzuki A, Tsutsumi H

    Child neurology open   3   2329048X16665758   2016.1

    　More details

  • 難治性てんかんに対するステロイドパルス治療の経験

    高山 留美子, 小笠原 真志, 福村 忍, 高橋 幸利, 渡邊 年秀

    てんかん研究   33 ( 2 )   544 - 544   2015.9

    　More details

    Language：Japanese   Publisher：(一社)日本てんかん学会  

    Ichushi

    researchmap

  • Compound heterozygous GFM2 mutations with Leigh syndrome complicated by arthrogryposis multiplex congenita Reviewed

    Shinobu Fukumura, Chihiro Ohba, Toshihide Watanabe, Kimio Minagawa, Masaru Shimura, Kei Murayama, Akira Ohtake, Hirotomo Saitsu, Naomichi Matsumoto, Hiroyuki Tsutsumi

    JOURNAL OF HUMAN GENETICS   60 ( 9 )   509 - 513   2015.9

    　More details

    Language：English   Publishing type：Research paper (scientific journal)  

    DOI： 10.1038/jhg.2015.57

    PubMed

    Web of Science

    researchmap

  • Everolimus Treatment for an Early Infantile Subependymal Giant Cell Astrocytoma With Tuberous Sclerosis Complex Reviewed

    Shinobu Fukumura, Toshihide Watanabe, Rumiko Takayama, Kimio Minagawa, Hiroyuki Tsutsumi

    JOURNAL OF CHILD NEUROLOGY   30 ( 9 )   1192 - 1195   2015.8

    　More details

    Language：English   Publishing type：Research paper (scientific journal)  

    DOI： 10.1177/0883073814544703

    PubMed

    Web of Science

    researchmap

  • 重症筋無力症眼筋型と鑑別を要した慢性進行性外眼筋麻痺の1例

    小笠原 真志, 福村 忍, 高山 留美子, 渡辺 年秀

    脳と発達   47 ( 4 )   314 - 314   2015.7

    　More details

    Language：Japanese   Publisher：(一社)日本小児神経学会  

    Ichushi

    researchmap

  • Paroxysmal Tonic Upward Gaze Complicating Angelman Syndrome Reviewed

    Shinobu Fukumura, Toshihide Watanabe, Rumiko Takayama, Hiroyuki Tsutsumi

    PEDIATRIC NEUROLOGY   52 ( 1 )   125 - 127   2015.1

    　More details

    Language：English   Publishing type：Research paper (scientific journal)  

    DOI： 10.1016/j.pediatrneurol.2014.08.022

    PubMed

    Web of Science

    researchmap

  • Importance of measuring blood level of lamotrigine for optimum dosing schedule Reviewed

    Kimio Minagawa, Toshihide Watanabe, Reiki Oyanagi, Shinobu Fukumura

    No To Hattatsu   46 ( 5 )   345 - 349   2014.9

    　More details

    Language：Japanese   Publishing type：Research paper (scientific journal)   Publisher：Japanese Society of Child Neurology  

    PubMed

    researchmap

  • Macrocephaly-capillary malformationの3例

    小笠原 真志, 福村 忍, 高山 留美子, 渡邊 年秀, 香取 さやか, 續 晶子, 須藤 章

    脳と発達   46 ( Suppl. )   S279 - S279   2014.5

    　More details

    Language：Japanese   Publisher：(一社)日本小児神経学会  

    Ichushi

    researchmap

  • Effect of neurotropin on chronic headaches in children Reviewed

    Yoshiaki Saito, Shinobu Fukumura, Takashi Saito, Hirofumi Komaki, Eiji Nakagawa, Kenji Sugai, Masayuki Sasaki

    No To Hattatsu   44 ( 6 )   477 - 481   2012.11

    　More details

    Language：Japanese   Publishing type：Research paper (scientific journal)  

    DOI： 10.11251/ojjscn.44.477

    PubMed

    researchmap

  • Progressive conduction defects and cardiac death in late infantile neuronal ceroid lipofuscinosis Reviewed

    Shinobu Fukumura, Yoshiaki Saito, Takashi Saito, Hirofumi Komaki, Eiji Nakagawa, Kenji Sugai, Masayuki Sasaki, Akira Oka, Itaru Takamisawa

    DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY   54 ( 7 )   663 - 666   2012.7

    　More details

    Language：English   Publishing type：Research paper (scientific journal)  

    DOI： 10.1111/j.1469-8749.2011.04170.x

    PubMed

    Web of Science

    researchmap

  • Perioral myoclonia with absencesの1例

    福村 忍, 齋藤 貴志, 斎藤 義朗, 小牧 宏文, 中川 栄二, 須貝 研司, 佐々木 征行, 佐藤 研

    脳と発達   44 ( Suppl. )   S218 - S218   2012.5

    　More details

    Language：Japanese   Publisher：(一社)日本小児神経学会  

    Ichushi

    researchmap

  • Somatic mosaicism in two unrelated patients with X-linked chronic granulomatous disease characterized by the presence of a small population of normal cells Reviewed

    Masafumi Yamada, Yuka Okura, Yasuto Suzuki, Shinobu Fukumura, Toru Miyazaki, Hisami Ikeda, Shun-Ichiro Takezaki, Nobuaki Kawamura, Ichiro Kobayashi, Tadashi Ariga

    GENE   497 ( 1 )   110 - 115   2012.4

    　More details

    Language：English   Publishing type：Research paper (scientific journal)  

    DOI： 10.1016/j.gene.2012.01.019

    PubMed

    Web of Science

    researchmap

  • てんかんの病態生理学の進歩 小児難治性てんかんにおけるNIRSを用いた言語優位半球決定の試み

    福村 忍, 中川 栄二, 真柄 慎一, 岡崎 哲也, 比屋根 真彦, 石山 昭彦, 齋藤 貴志, 斎藤 義朗, 小牧 宏文, 須貝 研司, 佐々木 征行, 高橋 章夫, 大槻 泰介

    臨床神経生理学   39 ( 5 )   395 - 395   2011.10

    　More details

    Language：Japanese   Publisher：(一社)日本臨床神経生理学会  

    Ichushi

    researchmap

  • A novel proteolipid protein 1 gene mutation causing classical type Pelizaeus-Merzbacher disease Reviewed

    Shinobu Fukumura, Noriaki Adachi, Masayoshi Nagao, Hiroyuki Tsutsumi

    BRAIN & DEVELOPMENT   33 ( 8 )   697 - 699   2011.9

    　More details

    Language：English   Publishing type：Research paper (scientific journal)  

    DOI： 10.1016/j.braindev.2010.11.010

    PubMed

    Web of Science

    researchmap

  • β2ミクログロブリンを用いた重症心身障害児(者)における近位尿細管障害の評価

    乾 健彦, 福村 忍, 苛原 香, 鋤柄 小百合, 服部 文子, 齋藤 貴志, 佐久間 啓, 斎藤 義朗, 小牧 宏文, 中川 栄二, 須貝 研司, 佐々木 征行

    日本重症心身障害学会誌   35 ( 2 )   305 - 305   2010.8

    　More details

    Language：Japanese   Publisher：日本重症心身障害学会  

    Ichushi

    researchmap

  • A case of Pitt-Hopkins syndrome

    FUKUMURA S, TACHI N

    NO TO HATTATSU   41 ( 5 )   365 - 367   2009.9

    　More details

    Language：Japanese   Publisher：The Japanese Society of Child Neurology  

    Other Link： http://search.jamas.or.jp/link/ui/2010027681

    DOI： 10.11251/ojjscn.41.365

    researchmap

  • 可逆性脳梁膨大部病変を伴った軽症急性脳症の2例

    會田 久美子, 小原 治枝, 神保 圭祐, 福村 忍, 鈴木 将史, 笹島 知大, 大屋 一博, 安保 亘, 対馬 史泰, 澁谷 剛一, 緑川 宏, 木村 義治

    臨床小児医学   55 ( 3-4 )   71 - 75   2007.8

    　More details

▼display all

MISC

  • 異なる表現型を呈したPLP1遺伝子バリアントの3例

    土田 晃輔, 福村 忍, 山本 晃代, 平出 拓也, 渡邊 一樹, 宮本 祥子, 中島 光子, 才津 浩智, 津川 毅

    脳と発達   54 ( Suppl. )   S262 - S262   2022.5

    　More details

    Language：Japanese   Publisher：(一社)日本小児神経学会  

    Ichushi

    researchmap

  • 当院の結節性硬化症ボードの現状と課題

    石川 亜貴, 田中 佑弥, 宮崎 幸子, 水上 都, 福村 忍, 越智 さと子, 鈴木 秀一郎, 肥田 時征, 廣川 直樹, 福多 史昌, 舛森 直哉, 櫻井 晃洋

    日本遺伝カウンセリング学会誌   40 ( 2 )   100 - 100   2019.7

    　More details

    Language：Japanese   Publisher：日本遺伝カウンセリング学会  

    Ichushi

    researchmap

  • 【小児の症候群】 神経・精神 Pitt-Hopkins症候群

    福村 忍, 舘 延忠

    小児科診療   79 ( 増刊 )   118 - 118   2016.4

    　More details

    Language：Japanese   Publisher：(株)診断と治療社  

    Ichushi

    researchmap

  • 単線維筋電図によって重症筋無力症を否定した心因性眼瞼下垂の1例

    川村 健太郎, 福村 忍, 二階堂 弘輝, 舘 延忠, 堤 裕幸, 今井 富裕

    脳と発達   47 ( 5 )   373 - 373   2015.9

    　More details

    Language：Japanese   Publisher：(一社)日本小児神経学会  

    Ichushi

    researchmap

  • Lamotrigineの適正投与量設定におけるlamotrigine血中濃度測定の重要性

    皆川 公夫, 渡邊 年秀, 大柳 玲嬉, 福村 忍

    脳と発達   46 ( 5 )   345 - 349   2014.9

    　More details

    Language：Japanese   Publisher：(一社)日本小児神経学会  

    DOI： 10.11251/ojjscn.46.345

    Ichushi

    researchmap

  • 症候性全般てんかんにおけるrufinamideの内服開始後の月数毎の効果

    渡邊 年秀, 高山 留美子, 福村 忍, 皆川 公夫

    てんかん研究   32 ( 2 )   395 - 395   2014.9

    　More details

    Language：Japanese   Publisher：(一社)日本てんかん学会  

    Ichushi

    researchmap

  • 新生児期にけいれんが先行した乳児型低フォスファターゼ症の1例

    小杉 陽祐, 浅沼 秀臣, 星野 陽子, 野口 聡子, 石川 淑, 新飯田 裕一, 福村 忍, 道上 敏美

    日本小児科学会雑誌   118 ( 6 )   923 - 929   2014.6

    　More details

    Language：Japanese   Publisher：(公社)日本小児科学会  

    日齢7男児。上肢の異常運動、異常な眼球運動を主訴とした。検査所見では血清ALPの著明低下、血清Caの上昇と尿中Phosphoethanolamine高値を示し、骨レントゲン写真で全身の長管骨骨端にくる病様所見を認めた。痙攣は抗痙攣薬に抵抗性で脳波異常も持続したため、低フォスファターゼ症(HPP)に伴うビタミンB6反応性発作と判断してビタミンB6製剤と低カルシウム乳を開始したところ、痙攣の消失と脳波の改善、血清Caの低下が得られた。また、遺伝子検査にてF310del/c.1559delTの複合ヘテロ接合体と判明し、臨床症状と併せて乳児型HPPの確定診断に至った。入院時に呼吸障害は認めなかったが、生後2ヵ月より呼吸障害が出現し、人工呼吸器管理となった。

    Other Link:： http://search.jamas.or.jp/link/ui/2014293810

    Ichushi

    researchmap

  • ACTH治療中にEpileptic spasmsが入眠期ミオクローヌスに変容した2例

    福村 忍, 渡邊 年秀, 皆川 公夫

    てんかんをめぐって   32   67 - 71   2013.12

    　More details

    Language：Japanese   Publisher：日本てんかん学会-北海道地方会  

    epileptic spasmsを呈した2症例に対し、副腎皮質刺激ホルモン(ACTH)療法を施行したところ、非てんかん性のシリーズ形成性攣縮に変容し、その臨床的、生理学的特徴から入眠期ミオクローヌスと診断した過程について報告した。症例1は生後10ヵ月よりepileptic spasmsが出現し、ACTH治療により浅眠時に周期的に攣縮発作に変化した。症例2は生後11ヵ月からepileptic spasmsが出現し、ACTH治療により浅眠時に周期的に攣縮発作を起こし、頻度が増大した。両症例ともACTHの治療後の攣縮は、発作時脳波と対応がなかった。入眠期にはACTH療法に反応がなく、また発達に影響を及ぼしていないという特徴から、入眠期ミオクローヌスと診断した。入眠時ミオクローヌスは、てんかん性のものは早急に治療が必要だが非てんかん性のものは自然快癒し、入眠時のみに生じる攣縮は、たとえシリーズ形成性であっても、発作時脳波発作対応がない場合には、追加治療が必要ないと考えられた。

    Ichushi

    researchmap

  • レベチラセタム初回量服用直後から発作が完全消失し、1〜2週間のハネムーン期間を認めた難治性てんかんの3例

    皆川 公夫, 渡邊 年秀, 福村 忍

    てんかんをめぐって   32   72 - 76   2013.12

    　More details

    Language：Japanese   Publisher：日本てんかん学会-北海道地方会  

    新規抗てんかん薬のレベチラセタム(LEV)の初回量服用直後に連日みられていた難治性発作が一旦完全消失し、1週間から2週間のハネムーン期間を認めた後に発作が再発してきた3症例を報告した。症例1は11歳男児、症候性局在関連てんかん、症例2は11歳男児、Doose症候群、症例3は26歳女性、Lennox-Gastaut syndromeであった。3例に共通するのは次の6点であった。(1)難治性てんかんで、LEV投与前は多剤投与によっても毎日の発作を認めていた。(2)LEV初回投与直後から発作が完全消失した。(3)発作の完全消失期間は1から2週間であった。(5)消失の間、異常な精神症状は認められなかった。(6)3例ともLEV導入時にラモトリギン(LTG)、クロバザム(CLB)を服用中であった。LEVは超早期効果と初期効果の減弱が強く認められた。このような短期間での変化については、現時点では不明であり、今後同様の症例を集積・分析し、本現象の機序の解明、対応方法などについて検討することが必要であることが指摘できた。

    Ichushi

    researchmap

  • 反復する横紋筋融解症を契機にCPT(カルニチンパルミトイルトランフェラーゼ)II欠損症と診断された1女児例

    菅沼栄介, 小林真弓, 平山まりこ, 杉山延喜, 松田晋一, 石黒寛之, 新村文男, 望月博之, 福村忍, 小牧宏文

    神奈川医学会雑誌   40 ( 1 )   2013

    　More details

  • Neurotropinが奏効した小児難治性慢性頭痛の2例

    斎藤 義朗, 福村 忍, 齋藤 貴志, 小牧 宏文, 中川 栄二, 須貝 研司, 佐々木 征行

    脳と発達   44 ( 6 )   477 - 481   2012.11

    　More details

    Language：Japanese   Publisher：(一社)日本小児神経学会  

    DOI： 10.11251/ojjscn.44.477

    Ichushi

    researchmap

  • 脳形成異常を主とする発達期脳障害の病因・病態と治療に関する研究 先天性要因による脳機能障害のNIRSによる発達機能解析

    中川栄二, 眞柄慎一, 岡崎哲也, 比屋根真彦, 福村忍, 石山昭彦

    脳形成異常を主とする発達期脳障害の病因・病態と治療に関する研究 平成23年度 総括・分担研究報告書   43 - 49   2012

    　More details

    Language：Japanese  

    J-GLOBAL

    researchmap

  • 亜急性硬化性全脳炎のNIRSを用いた治療評価の検討 Reviewed

    比屋根真彦, 中川栄二, 榎園崇, 岡崎哲也, 福村忍, 眞柄慎一, 斎藤貴志, 斎藤義朗, 小牧宏文, 須貝研司, 佐々木征行

    日本重症心身障害学会誌   36 ( 2 )   343 - 343   2011.8

    　More details

    Language：Japanese   Publisher：日本重症心身障害学会  

    Ichushi

    J-GLOBAL

    researchmap

  • Neurotropinが奏効した小児難治性慢性頭痛の2例

    斎藤 義朗, 福村 忍, 中川 英二, 齋藤 貴志, 小牧 宏文, 須貝 研司, 佐々木 征行

    脳と発達   43 ( Suppl. )   S329 - S329   2011.5

    　More details

    Language：Japanese   Publisher：(一社)日本小児神経学会  

    Ichushi

    researchmap

  • 驚愕てんかん発作時のNIRSを用いた脳血流変化の検討 Reviewed

    石山昭彦, 中川栄二, 相崎貢一, 鋤柄小百合, 竹下絵里, 岡崎哲也, 比屋根真彦, 福村忍, 佐久間啓, 斎藤義朗, 小牧宏文, 須貝研司, 佐々木征行

    てんかん研究   28 ( 3 )   490 - 491   2011.1

    　More details

  • Near-infrared spectroscopy-based assessment of ictal cerebral hemodynamics of a frontal area in startle epilepsy

    Akihiko Ishiyama, Eiji Nakagawa, Sayuri Sukigara, Tetsuya Okazaki, Masahiko Hiyane, Shinobu Fukumura, Hiroshi Sakuma, Yoshiaki Saito, Hirofumi Komaki, Kenji Sugai, Masayuki Sasaki, Iwao Kobayashi

    Journal of the Japan Epilepsy Society   29 ( 3 )   482 - 489   2011

    　More details

    Language：Japanese   Publisher：(一社)日本てんかん学会  

    DOI： 10.3805/jjes.29.482

    Ichushi

    researchmap

  • Application of a Microarray-Based Whole Mitochondrial DNA Sequence Analysis for Molecular Diagnosis of Mitochondrial Diseases

    Hiroyuki Ishiura, Yuji Takahashi, Shinobu Fukumura, Yoshiko Nomura, Ritsuko Hanajima, Yasuo Terao, Akihiro Yugeta, Jun Shimizu, Jun Goto, Shoji Tsuji

    NEUROLOGY   74 ( 9 )   A265 - A265   2010.3

    　More details

    Language：English   Publishing type：Research paper, summary (international conference)  

    Web of Science

    researchmap

  • 両側線条体壊死を呈しND3に新規変異を認めた複合体I単独欠損症の1例

    福村 忍, 坂井 拓朗, 池本 亘, 水江 伸夫, 足立 憲昭, 舘 延忠, 石浦 浩之, 後藤 順, 辻 省次, 村山 圭, 大竹 明

    脳と発達   41 ( 6 )   470 - 470   2009.11

    　More details

    Language：Japanese   Publisher：(一社)日本小児神経学会  

    Ichushi

    researchmap

  • BCG接種後の遷延するリンパ節腫脹から診断された慢性肉芽腫症の1例

    福村 忍, 足立 憲昭, 坂井 拓朗, 池本 亘, 水江 伸夫

    日本小児科学会雑誌   113 ( 10 )   1564 - 1567   2009.10

    　More details

    Language：Japanese   Publisher：(公社)日本小児科学会  

    生後5ヵ月のBCG接種後に、接種した側の腋窩リンパ節腫脹を認めた1歳2ヵ月男児症例について検討した。腋窩リンパ節腫脹は接種後6ヵ月を経ても縮小傾向なく、徐々に腫大したため、1歳時にリンパ節生検を行った。病理検査の結果、乾酪壊死を伴う類上皮肉芽腫を認め、BCG後のリンパ節炎と診断した。しかし、リンパ節炎はBCG後も遷延していることから、好中球の活性酸素産生能を測定した。発熱や肛門周囲膿瘍などの易感染性は認めなかったが、好中球の活性酸素産生能の低下を認めた。さらに、glycoprotein 91 phox(gp91phox)発現欠損とcytochrome b、beta subunit(CYBB)遺伝子変異を認め、gp91phox欠損型慢性肉芽腫症(CGD)のde novo例と診断した。BCG後の遷延するリンパ節腫脹の際にはCGDを念頭に置き、好中球活性酸素産生能検査を行うことが重要であると思われた。

    Other Link:： http://search.jamas.or.jp/link/ui/2010061261

    Ichushi

    researchmap

  • 同一遺伝子異常を持ちながら臨床型が異なるALD兄弟例

    福村 忍, 水江 伸夫, 坂井 拓朗, 稲澤 奈津子, 池本 亘, 足立 憲昭, 下澤 伸行

    小児科臨床   62 ( 3 )   457 - 461   2009.3

    　More details

    Language：Japanese   Publisher：(株)日本小児医事出版社  

    Other Link:： http://search.jamas.or.jp/link/ui/2009118780

    Ichushi

    researchmap

  • 知的障害を伴う染色体異常に合併した慢性炎症性脱髄性多発神経炎

    福村 忍, 足立 憲昭, 坂井 拓朗, 稲澤 奈津子, 池本 亘, 水江 伸夫

    小児科臨床   62 ( 1 )   109 - 113   2009.1

    　More details

    Language：Japanese   Publisher：(株)日本小児医事出版社  

    Other Link:： http://search.jamas.or.jp/link/ui/2009105014

    Ichushi

    researchmap

  • Case studies: A case of Krabbe's disease

    The Journal of clinical pediatrics,Sapporo   56 ( 3 )   95 - 98   2008.8

    　More details

  • 中脳周囲非動脈瘤性くも膜下出血の女児例

    福村 忍, 會田 久美子, 高山 留美子, 安保 亘

    日本小児科学会雑誌   112 ( 5 )   848 - 851   2008.5

    　More details

    Language：Japanese   Publisher：(公社)日本小児科学会  

    10歳女児。突然の頭痛を主訴とした。血糖が軽度上昇、髄液糖が低下していた。頭部CT、MRIで中脳周囲に限局したくも膜下出血を認めた。血小板、凝固系に異常はなかった。血管造影で脳動脈瘤やくも膜下出血の原因となる脳血管病変は認めず、脳幹周囲に限局した中脳周囲非動脈瘤性くも膜下出血(PNSH)と診断した。重篤な合併症はなく、保存的治療で軽快した。後遺症もなく発症から約1ヵ月後に退院し、再発も認めていない。

    Other Link:： http://search.jamas.or.jp/link/ui/2008296156

    Ichushi

    researchmap

  • オルニチントランスカルバミラーゼ欠損症の9歳女児例 感染による脳症と鑑別の重要性

    福村 忍, 大柄 貴寛, 會田 久美子, 高山 留美子, 安保 亘

    小児科臨床   60 ( 7 )   1547 - 1551   2007.7

    　More details

    Language：Japanese   Publisher：(株)日本小児医事出版社  

    Other Link:： http://search.jamas.or.jp/link/ui/2007261036

    Ichushi

    researchmap

  • 軽度低体温療法、好中球エラスターゼ阻害薬により後遺症なく救命しえた溺水の1例

    福村 忍, 間山 郁美, 會田 久美子, 高山 留美子, 安保 亘, 齋藤 兄治

    小児科臨床   60 ( 6 )   1206 - 1210   2007.6

    　More details

    Language：Japanese   Publisher：(株)日本小児医事出版社  

    Other Link:： http://search.jamas.or.jp/link/ui/2007226665

    Ichushi

    researchmap

  • A case of fibromyalgia

    The Journal of clinical pediatrics,Sapporo   55 ( 1 )   33 - 36   2007.4

    　More details

  • A case of systemic lupus erythematosus with the first episode of idiopathic thrombocytopenic purpura

    The Journal of clinical pediatrics,Sapporo   54 ( 5 )   99 - 102   2006.12

    　More details

  • 可逆性の脳梁膨大部病変を有した軽症脳症(MERS)の2例

    會田 久美子, 小原 治枝, 神保 圭佑, 福村 忍, 鈴木 将史, 笹島 知大, 大屋 一博, 安保 亘, 対馬 史泰, 澁谷 剛一, 緑川 宏, 木村 義治

    日本小児科学会雑誌   110 ( 9 )   1301 - 1301   2006.9

    　More details

    Language：Japanese   Publisher：(公社)日本小児科学会  

    Ichushi

    researchmap

  • 小腸血管腫より出血を来たしたBlue Rubber Bleb Nevus syndromeの1例

    福村 忍, 黒岩 由紀, 木下 和子, 沼崎 啓, 中田 修二, 堤 裕幸, 遠藤 高夫, 秦 史壮

    臨床小児医学   54 ( 3〜4 )   45 - 47   2006.8

    　More details

    Language：Japanese   Publisher：(財)小児愛育協会  

    Other Link:： http://search.jamas.or.jp/link/ui/2006321784

    Ichushi

    researchmap

  • 慢性反復性頭痛を呈したChiari奇形1型の1例

    福村 忍, 下山 真喜子, 大屋 一博

    臨床小児医学   54 ( 1 )   21 - 24   2006.4

    　More details

    Language：Japanese   Publisher：小児愛育協会  

    Other Link:： http://search.jamas.or.jp/link/ui/2006221969

    researchmap

  • WAGR症候群の1例

    鈴木 将史, 赤坂 英二郎, 福村 忍

    臨床小児医学   53 ( 5 )   103 - 105   2005.12

    　More details

    Language：Japanese   Publisher：小児愛育協会  

    Other Link:： http://search.jamas.or.jp/link/ui/2006139977

    researchmap

  • Q熱の1女児例

    大柳 玲嬉, 福村 忍, 布施 茂登

    臨床小児医学   53 ( 3 )   77 - 81   2005.8

    　More details

    Language：Japanese   Publisher：小児愛育協会  

    Other Link:： http://search.jamas.or.jp/link/ui/2006066733

    researchmap

  • 【新生児疾患】 在胎22週または出生体重400g未満の未熟児動脈管開存症に対して外科的閉鎖術が有効であった4例

    福村 忍, 池田 智文, 笹島 知大, 遠藤 泰史, 網塚 貴介, 安保 亘, 高橋 悟朗, 久我 俊彦, 畑 正樹

    小児科臨床   58 ( 8 )   1685 - 1690   2005.8

    　More details

    Language：Japanese   Publisher：(株)日本小児医事出版社  

    Other Link:： http://search.jamas.or.jp/link/ui/2005231088

    Ichushi

    researchmap

  • 硬膜下膿瘍を合併したB群β溶血性連鎖球菌による化膿性髄膜炎の1例

    大柳 玲嬉, 福村 忍, 布施 茂登

    臨床小児医学   52 ( 1 )   37 - 42   2004.4

    　More details

    Language：Japanese   Publisher：小児愛育協会  

    Other Link:： http://search.jamas.or.jp/link/ui/2005100845

    researchmap

  • Blue rubber bleb nevus syndromeの1女児例

    福村 忍, 春日 亜衣, 黒岩 由紀, 木下 和子, 沼崎 啓, 中田 修二, 堤 裕幸, 遠藤 高夫, 秦 史壮

    日本小児科学会雑誌   107 ( 3 )   594 - 594   2003.3

    　More details

    Language：Japanese   Publisher：(公社)日本小児科学会  

    Ichushi

    researchmap

▼display all

Awards

  • 優秀English Session賞

    2018.6   第60回日本小児神経学会学術集会  

    福村 忍

    　More details

  • 第１回優秀論文賞

    2016.3   日本小児神経学会北海道地方会  

    福村 忍

    　More details

  • 第4回奨励賞

    2012.3   日本小児神経学会北海道地方会  

    福村 忍

    　More details

Research Projects

  • Development of a novel treatment for intractable epilepsy using bone marrow mesenchymal stem cells and elucidation of its mechanis

    Grant number：22K07938  2022.4 - 2025.3

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research (C)  Grant-in-Aid for Scientific Research (C)

    　 More details

    Grant amount：\4290000 （ Direct Cost: \3300000 、 Indirect Cost：\990000 ）

    researchmap

  • Mesenchymal stem cells for brain injury of prematurity in a rat model.

    Grant number：20K08163  2020.4 - 2023.3

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

    　 More details

    Grant amount：\4290000 （ Direct Cost: \3300000 、 Indirect Cost：\990000 ）

    researchmap

  • The development of novel therapies for intractable epilepsy with bone marrow mesenchymal stem cells

    Grant number：19K08256  2019.4 - 2022.3

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research (C)  Grant-in-Aid for Scientific Research (C)

    Fukumura Shinobu

    　 More details

    Grant amount：\4290000 （ Direct Cost: \3300000 、 Indirect Cost：\990000 ）

    The present study tested the hypothesis that systemically infused mesenchymal stem cells (MSCs) improve epilepsy in a rat model of chronic epilepsy. Status epilepticus (SE) was induced using the lithium-pilocarpine injection. MSCs or vehicle (DMEM only, no cells) were administered intravenously to rats with chronic epilepsy on the 60th day after lithium-pilocarpine-induced SE. The number of seizures was lower in the MSC-treated group than in the vehicle-treated group. Furthermore, frequency analysis demonstrated that the percentage of gamma-band on the electroencephalography was also lower in the MSC-treated group than in the vehicle-treated group. These suggest that MSCs effectively reduced the number of seizures and excitability in the chronic phase of epilepsy.

    researchmap

  • 橋渡し研究支援 骨髄間葉系幹細胞移植による難治性慢性てんかんの革新的治療法の開発

    2018.8 - 2019.3

    ノーステック財団  札幌ライフサイエンス産業活性化事業 

    福村 忍

    　 More details

    Authorship：Principal investigator  Grant type：Competitive

    researchmap

  • スタートアップ支援 骨髄間葉系幹細胞移植による難治性てんかんの革新的治療法の開発

    2017.8 - 2018.3

    ノーステック財団  札幌ライフサイエンス産業活性化事業 

    福村 忍

    　 More details

    Authorship：Principal investigator  Grant type：Competitive

    researchmap

  • 骨髄間葉系幹細胞移植を用いた難治性てんかんに対する新規治療法の開発

    2016.4 - 2019.3

    日本学術振興会および文部科学省  科学研究費助成事業基盤研究C 

    福村 忍

    　 More details

    Authorship：Principal investigator  Grant type：Competitive

    researchmap

  • ＜奨励＞骨髄間葉系幹細胞移植による難治性てんかん治療の開発

    2015.4 - 2016.3

    公益財団法人 秋山記念生命科学振興財団  2015年度研究助成 

    福村 忍

    　 More details

    Authorship：Principal investigator  Grant type：Competitive

    researchmap

  • Ｈ26年度若手研究人材・ネットワーク育成補助金 難治性てんかんに対する骨髄間葉系幹細胞移植療法の開発

    2014.8 - 2015.3

    ノーステック財団  若手研究人材育成事業 

    福村 忍

    　 More details

    Authorship：Principal investigator  Grant type：Competitive

    researchmap

  • Therapeutic Effects of Intravenous Infusion of MSCs in Hypoxic-Ischemic Encephalopathy Rat

    Grant number：26462168  2014.4 - 2017.3

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

    Sakai Takuro, HONMOU Osamu

    　 More details

    Grant amount：\4160000 （ Direct Cost: \3200000 、 Indirect Cost：\960000 ）

    We aimed to investigate the effect of mesenchymal stem cells (MSCs) transplantation in a rat model of neonatal hypoxic-ischemic encephalopathy (HIE) by histological, MRI, and behavioral analysis. At postnatal day 7, rats were underwent HI by left common carotid artery occlusion followed by 120 min hypoxia (8% oxygen). At postnatal day 10, transplantation of MSCs was performed by intravenous injection. Compared with the vehicle (control) group, the MSC infused group showed a significant improvement in athletic performance by the evaluation with the beam walk test. The MRI also demonstrated that the MSC infused group showed a significant reduction of the ischemic volume compared to the vehicle group. Collectively, intravenous infusion of MSCs might provide therapeutic efficacy in a rat model of HIE.

    researchmap

▼display all